Meng Li, PhD — Assistant Professor of Research in Pharmacology — Scholars @ Weill Cornell Medicine

ScholarsBetaWeill Cornell Medicine

Highlights

1
Blood cancer discovery · 2021
MLMeng Li ZCZhengming Chen AMAri M. Melnick
PMID: 35019856PMCID: PMC9789686DOIFirst author25 citations

Publications

13

Funding

5 View NIH portfolio on RePORTER ↗

Active

2 grants

Co-I
Targeting Unmet Needs For B-cell Lymphomas
Leukemia & Lymphoma Society · 2022–2027
LLS 7027-23
MPI
Therapeutic Targeting of SIRT3 for Aggressive and Refractory Lymphomas
National Cancer Institute · 2023–2027
R01CA270243-04

Completed grants (3)

KP
MSK SPORE in Lymphoma
National Cancer Institute · 2016–2022 · via Sloan-Kettering Institute for Cancer Research
P50CA192937-01A1
KP
Project 6: Clinical Epigenetics in Hematological Malignancies
Leukemia & Lymphoma Society · 2015–2018 · via University of Florida
7006-13
KP
Center on the Microenvironment and Metastasis
National Cancer Institute · 2009–2015 · via Cornell University - Ithaca
U54CA143876-04